Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

ESMO open·2026

Same author

Humic acid aggregates with laccase and decreases the performance of the enzyme catalytic systems through various mechanisms.

International journal of biological macromolecules·2025

Same author

Links between international market trends, agricultural intensification and extreme sedimentation rates in a transboundary South American coastal lagoon.

The Science of the total environment·2025

Same author

Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features.

Actas dermo-sifiliograficas·2025

Same author

Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features.

Actas dermo-sifiliograficas·2025

Same author

The effect of fluvial avulsion on the Holocene chronostratigraphic record and the agricultural signal of the world's largest coastal lagoonal system.

The Science of the total environment·2024

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Neuroprotective actions of flavonoids.

C Gutierrez-Merino¹, C Lopez-Sanchez, R Lagoa

¹Dept. Biochemistry and Molecular Biology, Faculty of Sciences, University of Extremadura, Avenida de Elvas s/n, 06006 - Badajoz, Spain. carlosgm@unex.es

Current Medicinal Chemistry

|February 5, 2011

Summary

Flavonoids combat neurodegeneration by reducing oxidative stress through direct antioxidant action or pathway modulation. Their metabolites also offer antioxidant benefits, but brain bioavailability and specific reactive oxygen species (ROS) must be considered for effective therapies.

Related Experiment Videos

Last Updated: Jun 4, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

Neuroscience
Pharmacology
Biochemistry

Background:

Oxidative stress is a key factor in neurodegeneration.
Flavonoids act as antioxidants, directly or by modulating cellular pathways.
Flavonoid metabolism produces bioactive antioxidant derivatives.

Purpose of the Study:

To review neuroprotection by various flavonoids in cellular and animal models.
To discuss the role of flavonoid metabolites in antioxidant therapy.
To consider brain bioavailability and specific reactive oxygen species (ROS) in neurodegenerative diseases.

Main Methods:

Literature review of neuroprotection studies involving flavonoids.
Analysis of flavonoid metabolism and metabolite bioactivity.
Discussion of administration protocols and ROS involvement in neurodegeneration.

Main Results:

Flavonoids demonstrate neuroprotective effects through multiple antioxidant mechanisms.
Flavonoid metabolites retain significant antioxidant and neuroprotective potential.
Optimizing flavonoid therapy requires considering brain penetration and disease-specific ROS.

Conclusions:

Flavonoids show promise for treating neurodegenerative diseases due to their antioxidant properties.
Further research into flavonoid bioavailability and targeted ROS modulation is crucial for therapeutic development.
Flavonoids exhibit low toxicity, supporting their potential as pharmacological agents.